Skip to main content
. 2008 Apr;49(2):182–191. doi: 10.3325/cmj.2008.2.182

Table 1.

Genotype distribution of glutathione S-transferase M1 (GSTM1), glutathione S-transferase T1 (GSTT1), and epoxide hydrolase 1 (EPHX1) in patients with chronic obstructive pulmonary disease and healthy controls in a sample of Slovak population*

Genotype No. (%) of
OR (95% CI) for homozygous mutation P OR adjusted (95% CI) for homozygous mutation P
COPD cases controls
GSTM1:
  non-null genotype 88 (40.6) 75 (46.9)
  null genotype 129 (59.4) 85 (53.1) 1.29 (0.84-1.99) 0.221 1.34 (0.85-2.12) 0.208
GSTT1:
  non-null genotype 178 (82.0) 129 (80.6)
  null genotype 39 (18.0) 31 (19.4) 0.91 (0.52-1.60) 0.729 0.91 (0.51-1.64) 0.766
EPHX1 exon 3 codon 113:
  Tyr/Tyr 105 (48.4) 78 (48.8)
  Tyr/His 70 (32.3) 67 (41.9)
  His/His 42 (19.3) 15 (9.3) 2.32 (1.20-4.69) 0.008 1.79 (0.91-3.53) 0.093
EPHX1 exon 4 codon 139:
  His/His 140 (64.5) 91 (56.9)
  His/Arg 69 (31.8) 63 (39.4)
  Arg/Arg 8 (3.7) 6 (3.7) 0.98 (0.29-3.51) 0.974 0.61 (0.20-1.90) 0.393

*Abbreviations: COPD – chronic obstructive pulmonary disease; OR – odds ratio; CI – confidence interval.

†Adjusted for potential confounding factors (age, sex, and smoking status).